Citations for
1KCNE1, LQT5
Mechanisms of disease pathogenesis in long QT syndrome type 5.
Harmer SC, Wilson AJ, Aldridge R, Tinker A.
Am J Physiol Cell Physiol 298(2):C263-73. Epub 2009 Nov 11. 2010
2KCNE1, LQT5
The role of abnormal trafficking of KCNE1 in long QT syndrome 5.
Harmer SC, Tinker A.
Biochem Soc Trans 35(Pt 5):1074-6. Review.PMID: 17956282 2007
3KCNQ1, LQT1, KCNE1, KCNE2, LQT5, LQT6, SCN5A, LQT3, KCNH2, LQT2
Spectrum of pathogenic mutations and associated polymorphisms in a cohort of 44 unrelated patients with long QT syndrome.
Millat G, Chevalier P, Restier-Miron L, Da Costa A, Bouvagnet P, Kugener B, Fayol L, Gonzalez Armengod C, Oddou B, Chanavat V, Froidefond E, Perraudin R, Rousson R, Rodriguez-Lafrasse C.
Clin Genet 70(3):214-27. 2006
4KCNE1, KCNQ1, LQT1, LQT5
Dominant-negative I(Ks) suppression by KCNQ1-deltaF339 potassium channels linked to Romano-Ward syndrome.
Thomas D, Wimmer AB, Karle CA, Licka M, Alter M, Khalil M, Ulmer HE, Kathofer S, Kiehn J, Katus HA, Schoels W, Koenen M, Zehelein J.
Cardiovasc Res 67(3):487-97. 2005
5KCNE1, LQT5
Characterization of a novel Long QT syndrome mutation G52R-KCNE1 in a Chinese family.
Ma L, Lin C, Teng S, Chai Y, Bahring R, Vardanyan V, Li L, Pongs O, Hui R.
Cardiovasc Res 59(3):612-9. 2003
6KCNE2, LQT5
MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia.
Abbott GW, et al.
Cell 97(2):175-87. 1999
7KCNE2, LQT5
Cellular dysfunction of LQT5-minK mutants: abnormalities of IKs, IKr and trafficking in long QT syndrome.
Bianchi L, et al.
Hum Mol Genet 8(8):1499-507. 1999